journal article·2018-02

Bone extracellular matrix hydrogel enhances osteogenic differentiation of C2C12 myoblasts and mouse primary calvarial cells

Noura Alom, Heather Peto, Glen R. Kirkham, Kevin M. Shakesheff, Lisa J. White

Publisher page

Abstract

Abstract Hydrogel scaffolds derived from the extracellular matrix (ECM) of mammalian tissues have been successfully used to promote tissue repair in vitro and in vivo. The objective of this study was to evaluate the osteogenic potential of ECM hydrogels prepared from demineralized and decellularized bovine bone in the presence and absence of osteogenic medium. Culture of C2C12 and mouse primary calvarial cells (mPCs) on decellularized bone ECM (bECM) and demineralized bone matrix (DBM) gels resulted in increased expression of osteogenic gene markers, including a 3.6‐ and 13.4‐fold increase in osteopontin and 15.7‐ and 27.1‐fold increase in osteocalcin when mPCs were cultured upon bECM with basal and osteogenic media, respectively. bECM hydrogels stimulated the osteogenic differentiation of C2C12 and mPCs even in the absence of osteogenic medium. These results suggest that bECM hydrogel scaffolds may have great utility in future clinical applications for bone tissue engineering. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 900–908, 2018.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Regenerative Medicine and Cellular Therapies, School of Pharmacy University of Nottingham University Park Nottingham United Kingdom

References (59)

Show source-provided references
1. 10.1097/00003086-200002000-0000310.1097/00003086-200002000-00003 ↗
2. 10.1302/0301-620X.93B4.2524910.1302/0301-620X.93B4.25249 ↗
3. 10.2106/JBJS.G.0126010.2106/JBJS.G.01260 ↗
4. Orthopaedic applications of bone graft & graft substitutes: A review
5. 10.1016/j.biomaterials.2013.08.05410.1016/j.biomaterials.2013.08.054 ↗
6. Lichtenberg A · 2007 · 309
7. 10.1002/term.23710.1002/term.237 ↗
8. 10.1016/j.biomaterials.2011.01.05710.1016/j.biomaterials.2011.01.057 ↗
9. 10.1016/j.yexcr.2013.03.01610.1016/j.yexcr.2013.03.016 ↗
10. 10.1016/j.actbio.2013.04.02910.1016/j.actbio.2013.04.029 ↗
11. 10.1016/j.biomaterials.2010.06.05610.1016/j.biomaterials.2010.06.056 ↗
12. 10.1016/j.biomaterials.2012.06.05110.1016/j.biomaterials.2012.06.051 ↗
13. 10.1016/j.biomaterials.2007.12.01410.1016/j.biomaterials.2007.12.014 ↗
14. 10.1242/jcs.02382010.1242/jcs.023820 ↗
15. 10.1089/ten.2006.043710.1089/ten.2006.0437 ↗
16. 10.1038/nm.217010.1038/nm.2170 ↗
17. 10.1016/j.biomaterials.2009.04.00510.1016/j.biomaterials.2009.04.005 ↗
18. Decellularized matrices for cardiovascular tissue engineering
19. 10.1016/j.addr.2012.06.00810.1016/j.addr.2012.06.008 ↗
20. 10.1097/01.prs.0000232385.81219.8710.1097/01.prs.0000232385.81219.87 ↗
21. 10.2106/00004623-200410000-0001610.2106/00004623-200410000-00016 ↗
22. 10.1007/s00586-006-0282-x10.1007/s00586-006-0282-x ↗
23. 10.1097/00007632-200107010-0000810.1097/00007632-200107010-00008 ↗
24. 10.1097/00007632-200107010-0000710.1097/00007632-200107010-00007 ↗
25. Characterization of the inflammatory response to four commercial bone graft substitutes using a murine biocompatibility model
26. 10.1016/j.biomaterials.2011.10.05410.1016/j.biomaterials.2011.10.054 ↗
27. 10.1016/j.actbio.2014.06.01110.1016/j.actbio.2014.06.011 ↗
28. 10.1016/j.actbio.2014.05.02510.1016/j.actbio.2014.05.025 ↗
29. 10.1371/journal.pone.014508010.1371/journal.pone.0145080 ↗
30. 10.1016/j.spinee.2007.06.01410.1016/j.spinee.2007.06.014 ↗
31. 10.1016/S8756-3282(00)00358-610.1016/S8756-3282(00)00358-6 ↗
32. 10.1007/s00586-007-0351-910.1007/s00586-007-0351-9 ↗
33. 10.1007/s10561-009-9168-610.1007/s10561-009-9168-6 ↗
34. 10.1016/j.jsb.2003.08.00210.1016/j.jsb.2003.08.002 ↗
35. 10.1016/j.jbiomech.2008.09.02510.1016/j.jbiomech.2008.09.025 ↗
36. 10.1038/nmat109210.1038/nmat1092 ↗
37. 10.1016/j.lfs.2009.01.00410.1016/j.lfs.2009.01.004 ↗
38. 10.1016/S8756-3282(01)00617-210.1016/S8756-3282(01)00617-2 ↗
39. Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL‐1β, TNF‐α, and IFN‐γ10.1089/scd.2013.0336 ↗
40. The cell biology of bone growth
41. 10.1023/A:101001120906410.1023/A:1010011209064 ↗
42. 10.1016/j.scr.2013.09.00910.1016/j.scr.2013.09.009 ↗
43. C2C12 murine myoblasts as a model of skeletal muscle development: Morpho‐functional characterization
44. 10.1016/j.tibtech.2012.12.00410.1016/j.tibtech.2012.12.004 ↗
45. 10.1016/j.biomaterials.2004.04.00110.1016/j.biomaterials.2004.04.001 ↗
46. 10.1016/j.biomaterials.2011.01.02510.1016/j.biomaterials.2011.01.025 ↗
47. 10.1159/00012157510.1159/000121575 ↗
48. HollingerJO SchmittJM BuckDC ShannonR JohS‐P ZegzulaHD WozneyJ. Recombinant human bone morphogenetic protein‐2 and collagen for bone regeneration. J Biomed Mater Res1998;43:356–364.10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7 ↗
49. 10.1016/j.biomaterials.2006.10.01310.1016/j.biomaterials.2006.10.013 ↗
50. 10.1097/00003226-199911000-0001110.1097/00003226-199911000-00011 ↗
51. Type IV collagen, laminin, and fibronectin promote the adhesion and migration of rabbit lens epithelial cells in vitro
52. 10.1007/s10856-008-3687-810.1007/s10856-008-3687-8 ↗
53. 10.1006/bbrc.1999.128110.1006/bbrc.1999.1281 ↗
54. 10.1083/jcb.127.6.175510.1083/jcb.127.6.1755 ↗
55. 10.1002/jcp.2451210.1002/jcp.24512 ↗
56. 10.1210/er.21.2.11510.1210/er.21.2.115 ↗
57. 10.3892/etm.2011.39310.3892/etm.2011.393 ↗
58. 10.1371/journal.pone.003571210.1371/journal.pone.0035712 ↗
59. 10.7150/ijms.847310.7150/ijms.8473 ↗